SBRT With Immunotherapy in Early Stage Non-small Cell Lung Cancer: Tolerability and Lung Effects

Clinical trial NCT03383302 · COMPLETED

Trial details

NCT number: NCT03383302
Sponsor: Royal Marsden NHS Foundation Trust
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Stage II Non-small Cell Lung Cancer Stage I

Start date: 2018-02-08
Primary completion: 2024-08-12
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.